We just received data on a new analyst forecast for $EQIX. Philip Cusick from JP Morgan set a price target of 940.0 for EQIX.
To track analyst ratings and price targets for $EQIX, check out Quiver Quantitative's $EQIX forecast page.
$EQIX Price Targets
Multiple analysts have issued price targets for $EQIX recently. We have seen 16 analysts offer price targets for $EQIX in the last 6 months, with a median target of $945.0.
Here are some recent targets:
- Philip Cusick from JP Morgan set a target price of $940.0 on 07/31/2025
- Greg Miller from JMP Securities set a target price of $1200.0 on 07/22/2025
- John Hodulik from UBS set a target price of $950.0 on 07/11/2025
- Tim Long from Barclays set a target price of $798.0 on 07/11/2025
- Joseph Osha from Guggenheim set a target price of $933.0 on 07/10/2025
- James Schneider from Goldman Sachs set a target price of $880.0 on 07/02/2025
- Vikram Malhotra from Mizuho set a target price of $900.0 on 07/01/2025
$EQIX Congressional Stock Trading
Members of Congress have traded $EQIX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EQIX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$EQIX Insider Trading Activity
$EQIX insiders have traded $EQIX stock on the open market 176 times in the past 6 months. Of those trades, 0 have been purchases and 176 have been sales.
Here’s a breakdown of recent trading of $EQIX stock by insiders over the last 6 months:
- ADAIRE FOX-MARTIN (CEO and President) has made 0 purchases and 25 sales selling 7,405 shares for an estimated $6,601,162.
- CHARLES J MEYERS has made 0 purchases and 19 sales selling 4,481 shares for an estimated $4,079,780.
- BRANDI GALVIN MORANDI (Chief People Officer) has made 0 purchases and 23 sales selling 4,257 shares for an estimated $3,910,945.
- JONATHAN LIN (Chief Business Officer) has made 0 purchases and 32 sales selling 3,699 shares for an estimated $3,388,563.
- RAOUF ABDEL (EVP, Global Operations) has made 0 purchases and 18 sales selling 2,804 shares for an estimated $2,485,813.
- KEITH D TAYLOR (Chief Financial Officer) has made 0 purchases and 6 sales selling 2,454 shares for an estimated $2,280,595.
- KURT PLETCHER (Chief Legal Officer) has made 0 purchases and 19 sales selling 899 shares for an estimated $826,891.
- SIMON MILLER (Chief Accounting Officer) has made 0 purchases and 32 sales selling 674 shares for an estimated $593,839.
- CHRISTOPHER B PAISLEY has made 0 purchases and 2 sales selling 225 shares for an estimated $200,967.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EQIX Hedge Fund Activity
We have seen 562 institutional investors add shares of $EQIX stock to their portfolio, and 517 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALEO FINANCIAL ADVISORS, LLC added 8,154,365 shares (+298148.6%) to their portfolio in Q2 2025, for an estimated $6,486,552,726
- CAPITAL INTERNATIONAL INVESTORS removed 1,087,143 shares (-91.8%) from their portfolio in Q1 2025, for an estimated $886,402,045
- GAMMA INVESTING LLC removed 888,999 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $707,172,034
- PRICE T ROWE ASSOCIATES INC /MD/ removed 479,046 shares (-25.2%) from their portfolio in Q1 2025, for an estimated $390,590,156
- CAPITAL RESEARCH GLOBAL INVESTORS removed 474,473 shares (-43.2%) from their portfolio in Q1 2025, for an estimated $386,861,560
- QUBE RESEARCH & TECHNOLOGIES LTD added 298,278 shares (+742.1%) to their portfolio in Q1 2025, for an estimated $243,200,967
- JPMORGAN CHASE & CO added 282,753 shares (+21.6%) to their portfolio in Q1 2025, for an estimated $230,542,658
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
